eSectoral Survey Pharmaceutical Industry in Egypt November 2010 Sectoral survey: Pharmaceutical Industry Index Page 1. Introduction 2. Definition 3. Regulatory framework 3.1.Regulatory body 3.2.Pricing 3.3.TRIPS 3 4 4 4. Market analysis 4.1.Market structure 4.2.Consumption 4.3.Production 4.4.Key players 7 5. Trade 5.1.Exports 5.2.Imports 5.3.Balance of trade 9 6. SWOT analysis 7. Outlook 8. Recommendations 9. Conclusion Appendix References 11 12 13 13 2
Premium Pharmacology Generic drug Food and Drug Administration
Indian Pharmaceutical Industry Business Environment 3 Agenda • • • • • • • History Indian Pharmaceutical Evolution Facts and Figures Regulatory Framework Current ongoing activities SWOT Analysis The India Advantage 4 History • Bengal Chemicals and Pharmaceutical Works‚ Calcutta‚ the first Indian pharmaceutical company established in 1901 • Still exists as one of the 5 government owned drug manufacturers • Next 60 years saw most of the drugs imported from multinationals 5 History
Premium Pharmaceutical industry Pharmacology Clinical trial
Title: The Global Pharmaceutical Industry Date: 2011 August 20 Table of content Contents Page 1. Introduction 4 2. Pestel analysis of the global pharmaceutical industries 5-6 3. Drivers for change in the future of pharmaceutical 7 4. Five forces analysis on the global pharmaceutical industry 8-10 5. Threats to a big pharmaceutical company 11 6. Conclusion 12 7. Bibliography 13 Introduction The pharmaceutical industry According
Premium Pharmaceutical industry Generic drug Barriers to entry
A. Introduction Pfizer‚ US pharmaceutical company is one of the largest pharmaceutical companies in the world. Unfortunately‚ Pfizer faced challenges by macro-environment forces that affect their sales volume decline dramatically in 2011. PESTEL‚ Porter’s Five Forces and Industry Lift Cycle frameworks to be applied to analysis the broad macro-environment that affected Pfizer in the pharmaceutical industry. 1. PESTEL framework PESTEL (Appendix I) is classifies into six environmental influences
Premium Pharmaceutical industry Pharmacology Food and Drug Administration
at some point in their lives. Today the pharmaceutical industry is one of the biggest industries in the United States. The industry experienced a rapid growth rate (in the double digits) in the late 20th century which has now dropped into the single digits (Mullins‚ 2007). The global demand is driven by factors such as a worldwide increase in elderly population and a rising quality of life in developing nations. Time Magazine listed Generic Pharmaceutical Manufacturing as one of the top ten fastest
Premium Pharmacology Pharmaceutical industry Pharmacy
Pharmaceutical Pricing Strategy Ryan Ritchey American Military University November 22‚ 2009 Pharmaceutical companies are in constant pricing competition and innovative “idea wars” so to speak. Differential pricing‚ the specific price structuring and implementation‚ is the solution to resolving the conflict between pharmaceutical drug patents. There are always several different brands of drugs that can be prescribed or even bought over-the-counter‚ but the decision of the consumer or medical
Premium Pharmacology Pricing Generic drug
Facts: Kramer Pharmaceuticals‚ Inc. was a major manufacturer of prescription drugs for the medical and dental professions. It had a sales force of over 500 detailers‚ whose primary responsibility was calling regularly on hospital personnel‚ doctors‚ and dentists to describe the product line and to persuade these medical personnel to use and prescribe Kramer drugs. After having worked at Kramer for 12 years‚ Bob Marsh‚ a detailer of the company‚ was fired for unsatisfactory performance‚ poor attitude
Premium Boss Change Leadership
1. Political • Stringent government regulation and powerful purchaser pressures. • Governments focused on pharmaceuticals in efforts to control rising healthcare expenditure. • Inter-country pricing disparities. Economic • European free trade agreements. Social • Ageing populations create pressure on healthcare systems. • Epidemic or chronic diseases (e.g. obesity). Technological • Impact of genetic research on industry. • Utilizing a web of alliances to address multiple customer
Premium Generic drug Pharmaceutical industry Regulation
We recommend Meredith Collins reintroduce the loyalty program in Reed Supermarkets. Currently‚ they are leading the Columbus area with a 14% market share. With the recent evolution of the food retailing industry‚ this number has remained stable for two years with no growth and is susceptible to further decline. Throughout the recession‚ customer loyalty has significantly diminished and by implementing a redesigned loyalty program‚ Reed Supermarkets will be able to incorporate low pricing on products
Premium Marketing Variety store
Merck‚ being on one of the biggest pharmaceutical companies in the world today‚ came from a meek beginning and still encounters many problems today while trying to maintain a lead amongst its competition. While being looked at as a research and development driven company‚ Merck now has to go beyond R&D to stay competitive in the pharmaceutical industry. Attracting talent to work for the company has never been a problem for Merck‚ but the bigger question was whether or not this talent would be able
Premium Pharmaceutical industry Pharmacology Generic drug